314 related articles for article (PubMed ID: 16423352)
1. Chronic disruption of body weight but not of stress peptides or receptors in rats exposed to repeated restraint stress.
Harris RB; Palmondon J; Leshin S; Flatt WP; Richard D
Horm Behav; 2006 May; 49(5):615-25. PubMed ID: 16423352
[TBL] [Abstract][Full Text] [Related]
2. mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration.
Cespedes IC; de Oliveira AR; da Silva JM; da Silva AV; Sita LV; Bittencourt JC
Peptides; 2010 Dec; 31(12):2200-8. PubMed ID: 20833218
[TBL] [Abstract][Full Text] [Related]
3. Habituation to repeated restraint stress is associated with lack of stress-induced c-fos expression in primary sensory processing areas of the rat brain.
Girotti M; Pace TW; Gaylord RI; Rubin BA; Herman JP; Spencer RL
Neuroscience; 2006; 138(4):1067-81. PubMed ID: 16431027
[TBL] [Abstract][Full Text] [Related]
4. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
5. Chronic psychosocial stress affects corticotropin-releasing factor in the paraventricular nucleus and central extended amygdala as well as urocortin 1 in the non-preganglionic Edinger-Westphal nucleus of the tree shrew.
Kozicz T; Bordewin LA; Czéh B; Fuchs E; Roubos EW
Psychoneuroendocrinology; 2008 Jul; 33(6):741-54. PubMed ID: 18394812
[TBL] [Abstract][Full Text] [Related]
6. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
7. Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress.
Pournajafi-Nazarloo H; Partoo L; Sanzenbacher L; Azizi F; Carter CS
Neuroendocrinology; 2007; 86(1):17-25. PubMed ID: 17551267
[TBL] [Abstract][Full Text] [Related]
8. Regulation of corticotropin-releasing factor and its types 1 and 2 receptors by leptin in rats subjected to treadmill running-induced stress.
Huang Q; Timofeeva E; Richard D
J Endocrinol; 2006 Oct; 191(1):179-88. PubMed ID: 17065401
[TBL] [Abstract][Full Text] [Related]
9. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
[TBL] [Abstract][Full Text] [Related]
10. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint.
Zelena D; Mergl Z; Foldes A; Kovács KJ; Tóth Z; Makara GB
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1110-7. PubMed ID: 14534078
[TBL] [Abstract][Full Text] [Related]
11. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
12. Stress differentially modulates mRNA expression for corticotrophin-releasing hormone receptors in hypothalamus, hippocampus and pituitary of prairie voles.
Pournajafi-Nazarloo H; Partoo L; Sanzenbacher L; Paredes J; Hashimoto K; Azizi F; Sue Carter C
Neuropeptides; 2009 Apr; 43(2):113-23. PubMed ID: 19185916
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic expression of urocortin 3 and the type 2 corticotropin-releasing factor receptor is regulated according to feeding state in lean but not obese Zucker rats.
Poulin AM; Lenglos C; Mitra A; Timofeeva E
Neuropharmacology; 2012 Jul; 63(1):147-53. PubMed ID: 22227020
[TBL] [Abstract][Full Text] [Related]
14. Effects of repeated tianeptine treatment on CRF mRNA expression in non-stressed and chronic mild stress-exposed rats.
Kim SJ; Park SH; Choi SH; Moon BH; Lee KJ; Kang SW; Lee MS; Choi SH; Chun BG; Shin KH
Neuropharmacology; 2006 Jun; 50(7):824-33. PubMed ID: 16504218
[TBL] [Abstract][Full Text] [Related]
15. Colocalization of urocortin and neuronal nitric oxide synthase in the hypothalamus and Edinger-Westphal nucleus of the rat.
Spina MG; Langnaese K; Orlando GF; Horn TF; Rivier J; Vale WW; Wolf G; Engelmann M
J Comp Neurol; 2004 Nov; 479(3):271-86. PubMed ID: 15457505
[TBL] [Abstract][Full Text] [Related]
16. Desipramine prevents the sustained increase in corticotropin-releasing hormone-like immunoreactivity induced by repeated immobilization stress in the rat central extended amygdala.
Santibañez M; Gysling K; Forray MI
J Neurosci Res; 2006 Nov; 84(6):1270-81. PubMed ID: 16941481
[TBL] [Abstract][Full Text] [Related]
17. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress.
Makino S; Asaba K; Nishiyama M; Hashimoto K
Neuroendocrinology; 1999 Sep; 70(3):160-7. PubMed ID: 10516478
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic circuit regulating colonic transit following chronic stress in rats.
Yoshimoto S; Cerjak D; Babygirija R; Bulbul M; Ludwig K; Takahashi T
Stress; 2012 Mar; 15(2):227-36. PubMed ID: 21936687
[TBL] [Abstract][Full Text] [Related]
19. Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours.
Venihaki M; Sakihara S; Subramanian S; Dikkes P; Weninger SC; Liapakis G; Graf T; Majzoub JA
J Neuroendocrinol; 2004 May; 16(5):411-22. PubMed ID: 15117334
[TBL] [Abstract][Full Text] [Related]
20. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.
Li C; Vaughan J; Sawchenko PE; Vale WW
J Neurosci; 2002 Feb; 22(3):991-1001. PubMed ID: 11826127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
